[1]
Pękala, A. 2022. Monitoring of infliximab treatment in inflammatory bowel diseases – basic knowledge and current data based on clinical trials in a population of Polish patients. European Journal of Clinical and Experimental Medicine. 20, 3 (Sep. 2022), 251–259. DOI:https://doi.org/10.15584/ejcem.2022.3.1.